Anterix (ATEX) Shares Just Moved, So What Is Driving Attention Now?
Anterix (ATEX) is back in focus after a first quarter update on August 11 and an ESOP related shelf registration for up to 1,000,000 common shares, totaling about US$88.68 million, on August 20.
See our latest analysis for Anterix.
The recent 1 day share price return of 9.31% and 90 day return of 46.69% suggest fresh momentum around Anterix, even after a 30 day share price pullback of 10.33% and a 1 year total shareholder return of 315.37%.
If the ESOP related shelf registration has you thinking about where else capital is moving in infrastructure linked stories, it can be worth scanning 39 power grid technology and infrastructure stocks
Anterix has already delivered a very large 1 year return, yet the stock still trades below the average analyst target and only recently cooled after strong gains. Is most of the rerating already behind it, or does the valuation still leave room?
Most Popular Narrative: 8% Overvalued
The most followed Anterix narrative pegs fair value at $86, which is below the last close at $93.25. That gap all comes down to how quickly spectrum can be turned into cash and earnings.
Although utilities are showing interest in private broadband networks as they modernize grids, Anterix still has roughly 85% of its spectrum yet to be monetized. Any delay in converting that interest into contracts could slow the realization of expected spectrum value and defer cash inflows and earnings.
Want to see what is really baked into that $86 figure? The narrative hinges on measured revenue growth, a sharp reset in earnings, and a towering future earnings multiple that only works if a specific glide path plays out.
Result: Fair Value of $86.00 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Anterix still relies on monetizing roughly 85% of its 900 MHz spectrum and clearing remaining systems, so slower contracts or FCC timing could easily challenge this fair value story.
Find out about the key risks to this Anterix narrative.
Next Steps
If the mix of optimism and caution around Anterix leaves you uncertain, take prompt action and review the full picture for yourself with 1 key reward and 4 important warning signs
Looking for more investment ideas beyond Anterix?
If you are serious about building a stronger portfolio, do not stop at Anterix. Use the Simply Wall Street Screener to uncover other opportunities that fit your style.
- Target income potential with companies that have higher yields and sturdy profiles through 12 dividend fortresses.
- Hunt for quality businesses that the market may be overlooking by starting with screener containing 19 high quality undiscovered gems.
- Focus on steadier candidates that may help smooth portfolio swings by filtering through 78 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com